Clinical Trial Update: Therapy With Bevacizumab (BEV), Doxorubicin, and Cyclophosphamide Followed by BEV, Docetaxel, and Capecitabine Before Surgery Followed by BEV Alone After Surgery for Women With Locally Advanced Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a BEV-containing neoadjuvant/adjuvant regimen for locally advanced breast cancer shows completed results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Capecitabine (capecitabine)
• DOCETAXEL (DOCETAXEL)
• Doxorubicin (doxorubicin)

Snippet

Sponsor: NSABP Foundation Inc | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2010-08-12